The International Tennis Integrity Agency (ITIA) can today confirm that an agreement has been reached with American player Jenson Brooksby, which sees their period of ineligibility reduced to 13 months.
In October 2023, Brooksby - who reached a career-high world singles ranking of 33 in 2022 - was issued an 18-month suspension by an independent tribunal for missing three anti-doping tests in a 12-month period. However, new information relating to the circumstances giving rise to the missed tests - which had not previously been available to the ITIA or the independent tribunal during the initial hearing - was submitted as part of the player’s Court of Arbitration for Sport (CAS) appeal proceedings.
On the basis of a detailed review of the new information, the ITIA, in consultation with the World Anti-Doping Agency (WADA), determined that the player’s degree of fault for the Anti-Doping Rule Violation (ADRV) should be reassessed.
Following reassessment, the ITIA, WADA, and the player’s representatives agreed that Brooksby’s fault for the ADRV was not as high as previously found by the independent tribunal, and a 13-month sanction was appropriate. The sanction will be backdated to the date of the player’s third and final missed test. As such, Brooksby’s suspension is deemed to have begun on 4 February 2023, and will end on 3 March 2024. In reaching an agreement with the ITIA, the player has withdrawn their appeal to CAS.
Due to the nature of the new information disclosed, it is not possible for the ITIA to discuss the specific details behind the reassessment or offer further comment.
Ends
Published 15 February 2024 16:00
